USPTO Director Review Is A Rare Remedy After Arthrex
On June 21, 2021, the U.S. Supreme Court decided the highly anticipated U.S. v. Arthrex Inc. case.[1] A 5-4 majority concluded that the America Invents Act grants "unreviewable authority" within the executive...To view the full article, register now.
Already a subscriber? Click here to view full article